This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Good-IP Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Are Thoresen: Innovator in Non-Invasive Medical Treatments
Introduction
Are Thoresen is a notable inventor based in Sandefjord, Norway. He has made significant contributions to the field of non-invasive medical treatments, particularly in the area of neoplastic processes in both animals and humans. With a total of 2 patents, Thoresen's work is paving the way for innovative approaches to health care.
Latest Patents
Thoresen's latest patents include methods for the prevention, detection, treatment, and healing of neoplastic processes in dogs and cats. This invention involves the stimulation of specific new acupuncture points that have not been previously disclosed for treating such conditions. The treatments can be administered by accredited practitioners in clinical settings or by laypersons. Various techniques can be used for stimulation, including traditional acupuncture needles, electric acupuncture, acupressure, and lasers, among others.
Another significant patent focuses on non-invasive methods for humans, utilizing similar techniques to prevent, detect, treat, and heal neoplastic processes. This method also allows patients to perform treatments at home, enhancing accessibility and convenience.
Career Highlights
Thoresen's career is marked by his dedication to advancing medical treatments through innovative methods. His work has garnered attention for its potential to improve the quality of life for both pets and humans suffering from neoplastic conditions.
Collaborations
Thoresen collaborates with Michael Schlosser, contributing to the development and refinement of his innovative methods. Their partnership exemplifies the importance of teamwork in the field of medical innovation.
Conclusion
Are Thoresen's contributions to non-invasive medical treatments represent a significant advancement in the field. His innovative patents are set to change the landscape of how neoplastic processes are treated in both animals and humans.